You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

GLENMARK PHARMS LTD Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS LTD, and what generic and branded alternatives to GLENMARK PHARMS LTD drugs are available?

GLENMARK PHARMS LTD has one hundred and forty-three approved drugs.

There are eight tentative approvals on GLENMARK PHARMS LTD drugs.

Summary for GLENMARK PHARMS LTD

US Patents:	0
Tradenames:	117
Ingredients:	108
NDAs:	143

Drugs and US Patents for GLENMARK PHARMS LTD

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Pharms Ltd	DIMETHYL FUMARATE	dimethyl fumarate	CAPSULE, DELAYED RELEASE;ORAL	210309-001	Oct 6, 2020	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Glenmark Pharms Ltd	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	090828-002	Dec 22, 2010	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Glenmark Pharms Ltd	THEOPHYLLINE	theophylline	TABLET, EXTENDED RELEASE;ORAL	212184-002	Jun 3, 2021	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Glenmark Pharms Ltd	ATOMOXETINE HYDROCHLORIDE	atomoxetine hydrochloride	CAPSULE;ORAL	079019-001	May 30, 2017	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Glenmark Pharms Ltd	ALYACEN 7/7/7	ethinyl estradiol; norethindrone	TABLET;ORAL-28	091636-001	Jan 19, 2012	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Glenmark Pharms Ltd	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	090135-007	Feb 25, 2010	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for GLENMARK PHARMS LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.